Symbols / ITRM $0.03 Iterum Therapeutics PLC

Healthcare • Biotechnology • Ireland • NGM
ITRM Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel anti-infective compound with oral and intravenous formulations to treat uncomplicated urinatry tract infections, complicated urinary tract infections, and complicated intra-abdominal infections, as well as community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory diseases. Iterum Therapeutics plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Fundamentals
Scroll to Statements
Market Cap 1.60M Enterprise Value 25.37M Income -26.96M Sales 390.00K Book/sh -0.15 Cash/sh 0.21
Dividend Yield — Payout 0.00% Employees 9 IPO May 25, 2018 P/E — Forward P/E -0.05
PEG — P/S 4.10 P/B — P/C — EV/EBITDA -1.31 EV/Sales 65.04
Quick Ratio 1.80 Current Ratio 2.13 Debt/Eq — LT Debt/Eq — EPS (ttm) -0.72 EPS next Y -0.66
EPS Growth — Revenue Growth — Earnings 2026-04-29 ROA -53.28% ROE — ROIC —
Gross Margin 29.74% Oper. Margin -19.82% Profit Margin 0.00% Shs Outstand 53.29M Shs Float 52.37M Short Float 5.80%
Short Ratio 2.36 Short Interest — 52W High 1.42 52W Low 0.03 Beta 3.01 Avg Volume 16.33M
Volume 49.30M Target Price — Recom Hold Prev Close $0.00 Price $0.03 Change —
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.03
Latest analyst target
3. DCF / Fair value
$-4.68
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.03
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-30 down HC Wainwright & Co. Buy → Neutral —
2024-08-15 main HC Wainwright & Co. Buy → Buy $5
2024-06-21 reit HC Wainwright & Co. Buy → Buy $6
2024-05-31 reit HC Wainwright & Co. Buy → Buy $6
2024-05-14 reit HC Wainwright & Co. Buy → Buy $6
2024-04-30 reit HC Wainwright & Co. Buy → Buy $6
2024-04-01 reit HC Wainwright & Co. Buy → Buy $6
2024-03-06 reit HC Wainwright & Co. Buy → Buy $6
2024-02-07 up HC Wainwright & Co. Neutral → Buy $6
News
RSS: Latest ITRM news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-11-18 DUNNE MICHAEL W Director — 6,000 $0.37 $2,191
2025-08-08 DUNNE MICHAEL W Director — 15,000 $0.72 $10,854
2024-08-06 HUNT RONALD M Director — 247,934 — —
2024-08-06 FISHMAN COREY N Chief Executive Officer — 82,613 — —
2024-08-06 DUNNE MICHAEL W Director — 106,247 $1.21 $128,559
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Cost Of Revenue
0.25
0.00
0.00
—
Reconciled Cost Of Revenue
0.25
0.00
0.00
—
Gross Profit
-0.25
0.00
0.00
—
Operating Expense
18.44
-61.15%
47.47
+56.23%
30.38
+23.83%
24.54
Research And Development
10.46
-73.85%
39.99
+127.01%
17.62
+64.46%
10.71
Selling General And Administration
7.98
+6.80%
7.48
-41.44%
12.77
-7.66%
13.82
General And Administrative Expense
7.98
+6.80%
7.48
-41.44%
12.77
-7.66%
13.82
Salaries And Wages
3.19
-11.94%
3.62
-41.20%
6.15
+26.34%
4.87
Other Gand A
4.80
+24.36%
3.86
-41.66%
6.61
-26.15%
8.96
Total Expenses
18.70
-60.61%
47.47
+56.23%
30.38
+23.83%
24.54
Operating Income
-18.70
+60.61%
-47.47
-56.23%
-30.38
-23.83%
-24.54
Total Operating Income As Reported
-18.70
+60.61%
-47.47
-56.23%
-30.38
-23.83%
-24.54
EBITDA
-21.73
+37.17%
-34.58
+13.49%
-39.97
+51.96%
-83.20
Normalized EBITDA
-18.46
+59.55%
-45.64
-0.45%
-45.43
-104.29%
-22.24
Reconciled Depreciation
0.28
-83.77%
1.75
-2.78%
1.80
-14.45%
2.10
EBIT
-22.01
+39.41%
-36.33
+13.03%
-41.77
+51.03%
-85.31
Total Unusual Items
-3.27
-129.57%
11.06
+102.57%
5.46
+108.95%
-60.96
Total Unusual Items Excluding Goodwill
-3.27
-129.57%
11.06
+102.57%
5.46
+108.95%
-60.96
Special Income Charges
—
—
0.00
0.00
Net Income
-24.77
+35.44%
-38.37
+13.64%
-44.43
+51.47%
-91.56
Pretax Income
-24.53
+35.02%
-37.76
+14.44%
-44.13
+51.43%
-90.86
Net Non Operating Interest Income Expense
-2.52
-76.61%
-1.43
+39.52%
-2.36
+57.48%
-5.55
Interest Expense Non Operating
2.52
+76.61%
1.43
-39.52%
2.36
-57.48%
5.55
Net Interest Income
-2.52
-76.61%
-1.43
+39.52%
-2.36
+57.48%
-5.55
Interest Expense
2.52
+76.61%
1.43
-39.52%
2.36
-57.48%
5.55
Other Income Expense
-3.32
-129.77%
11.14
+197.80%
-11.39
+81.26%
-60.77
Other Non Operating Income Expenses
-0.05
-157.32%
0.08
+100.49%
-16.85
-8739.49%
0.20
Gain On Sale Of Security
-3.27
-129.57%
11.06
+102.57%
5.46
+108.95%
-60.96
Tax Provision
0.24
-60.85%
0.61
+103.65%
0.30
-57.30%
0.70
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-0.41
-129.57%
1.38
+102.57%
0.68
+108.95%
-7.62
Net Income Including Noncontrolling Interests
-24.77
+35.44%
-38.37
+13.64%
-44.43
+51.47%
-91.56
Net Income From Continuing Operation Net Minority Interest
-24.77
+35.44%
-38.37
+13.64%
-44.43
+51.47%
-91.56
Net Income From Continuing And Discontinued Operation
-24.77
+35.44%
-38.37
+13.64%
-44.43
+51.47%
-91.56
Net Income Continuous Operations
-24.77
+35.44%
-38.37
+13.64%
-44.43
+51.47%
-91.56
Normalized Income
-21.91
+54.39%
-48.05
+2.37%
-49.21
-28.75%
-38.22
Net Income Common Stockholders
-24.77
+35.44%
-38.37
+13.64%
-44.43
+51.47%
-91.56
Diluted EPS
-1.26
+53.83%
-2.73
+18.46%
-3.35
+56.79%
-7.74
Basic EPS
-1.26
+53.83%
-2.73
+18.46%
-3.35
+56.79%
-7.74
Basic Average Shares
19.70
+40.11%
14.06
+5.93%
13.27
+12.35%
11.81
Diluted Average Shares
19.70
+40.11%
14.06
+5.93%
13.27
+12.35%
11.81
Diluted NI Availto Com Stockholders
-24.77
+35.44%
-38.37
+13.64%
-44.43
+51.47%
-91.56
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
44.59
+69.83%
26.26
-60.71%
66.83
-26.97%
91.51
Current Assets
24.79
-3.16%
25.60
-59.01%
62.44
-25.01%
83.27
Cash Cash Equivalents And Short Term Investments
24.12
+0.81%
23.93
-60.64%
60.80
-25.28%
81.38
Cash And Cash Equivalents
24.12
+297.38%
6.07
-71.22%
21.09
-23.15%
27.45
Other Short Term Investments
0.00
-100.00%
17.86
-55.03%
39.71
-26.37%
53.94
Receivables
0.07
-71.67%
0.23
-44.52%
0.42
-65.15%
1.21
Taxes Receivable
0.07
-71.67%
0.23
-44.52%
0.42
-54.10%
0.92
Accrued Interest Receivable
—
—
0.06
-81.03%
0.29
Prepaid Assets
0.53
-62.94%
1.43
+17.46%
1.22
+79.41%
0.68
Restricted Cash
—
—
—
0.00
Other Current Assets
0.07
—
—
—
Total Non Current Assets
19.81
+2887.63%
0.66
-84.89%
4.39
-46.75%
8.24
Net PPE
0.02
-54.90%
0.05
-26.09%
0.07
-24.18%
0.09
Gross PPE
0.36
-0.82%
0.37
+3.68%
0.35
-6.37%
0.38
Accumulated Depreciation
-0.34
-7.94%
-0.32
-10.92%
-0.28
+0.70%
-0.29
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.21
-1.38%
0.22
+6.34%
0.20
+43.36%
0.14
Other Properties
—
—
—
0.09
Leases
0.15
+0.00%
0.15
+0.00%
0.15
+0.00%
0.15
Goodwill And Other Intangible Assets
19.75
0.00
-100.00%
1.72
-49.96%
3.44
Other Non Current Assets
0.04
-93.63%
0.61
-76.47%
2.60
-44.86%
4.72
Total Liabilities Net Minority Interest
48.68
+49.03%
32.66
-15.89%
38.83
-5.91%
41.27
Current Liabilities
17.61
+30.23%
13.52
+49.14%
9.06
-29.96%
12.94
Payables And Accrued Expenses
2.90
-77.25%
12.76
+79.17%
7.12
+214.49%
2.26
Payables
0.25
-94.98%
5.00
+80.10%
2.77
+152.41%
1.10
Accounts Payable
0.25
-94.98%
5.00
+80.10%
2.77
+215.95%
0.88
Current Accrued Expenses
2.65
-65.84%
7.76
+78.58%
4.35
+273.05%
1.17
Total Tax Payable
—
—
0.00
-100.00%
0.22
Income Tax Payable
—
—
0.00
-100.00%
0.22
Current Debt And Capital Lease Obligation
14.46
—
—
1.63
Current Debt
14.46
—
—
1.63
Other Current Borrowings
14.46
—
—
1.63
Other Current Liabilities
0.24
-68.46%
0.76
-60.85%
1.94
-78.52%
9.05
Total Non Current Liabilities Net Minority Interest
31.07
+62.30%
19.14
-35.69%
29.77
+5.07%
28.33
Long Term Debt And Capital Lease Obligation
31.07
+63.91%
18.96
-33.41%
28.47
+14.33%
24.90
Long Term Debt
31.07
+63.91%
18.96
-33.41%
28.47
+14.33%
24.90
Other Non Current Liabilities
—
0.19
-85.58%
1.30
-62.05%
3.44
Stockholders Equity
-4.08
+36.26%
-6.40
-122.87%
28.00
-44.26%
50.23
Common Stock Equity
-4.08
+36.26%
-6.40
-122.87%
28.00
-44.26%
50.23
Capital Stock
0.32
+133.33%
0.14
+7.14%
0.13
+3.28%
0.12
Common Stock
0.32
+133.33%
0.14
+7.14%
0.13
+3.28%
0.12
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
31.53
+115.37%
14.64
+7.15%
13.67
+3.39%
13.22
Ordinary Shares Number
31.53
+115.37%
14.64
+7.15%
13.67
+3.39%
13.22
Additional Paid In Capital
481.68
+5.92%
454.76
+0.80%
451.15
+5.26%
428.61
Retained Earnings
-486.07
-5.37%
-461.30
-9.07%
-422.93
-11.74%
-378.49
Gains Losses Not Affecting Retained Earnings
0.00
-100.00%
0.00
+100.29%
-0.35
0.00
Other Equity Adjustments
—
0.00
+100.29%
-0.35
—
Total Equity Gross Minority Interest
-4.08
+36.26%
-6.40
-122.87%
28.00
-44.26%
50.23
Total Capitalization
26.99
+115.01%
12.55
-77.77%
56.47
-24.85%
75.13
Working Capital
7.18
-40.54%
12.08
-77.37%
53.38
-24.10%
70.33
Invested Capital
41.45
+230.22%
12.55
-77.77%
56.47
-26.44%
76.76
Total Debt
45.53
+140.21%
18.96
-33.41%
28.47
+7.32%
26.52
Net Debt
21.41
+66.15%
12.88
+74.74%
7.37
—
Net Tangible Assets
-23.83
-272.12%
-6.40
-124.36%
26.28
-43.84%
46.80
Tangible Book Value
-23.83
-272.12%
-6.40
-124.36%
26.28
-43.84%
46.80
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-26.77
+31.93%
-39.33
-112.91%
-18.47
-16.61%
-15.84
Cash Flow From Continuing Operating Activities
-26.77
+31.93%
-39.33
-112.91%
-18.47
-16.61%
-15.84
Net Income From Continuing Operations
-24.77
+35.44%
-38.37
+13.64%
-44.43
+51.47%
-91.56
Depreciation Amortization Depletion
0.28
-83.77%
1.75
-2.78%
1.80
-14.45%
2.10
Depreciation
0.03
-3.23%
0.03
-63.10%
0.08
-78.52%
0.39
Amortization Cash Flow
0.25
-85.22%
1.72
+0.17%
1.72
+0.18%
1.71
Depreciation And Amortization
0.28
-83.77%
1.75
-2.78%
1.80
-14.45%
2.10
Amortization Of Intangibles
0.25
-85.22%
1.72
+0.17%
1.72
+0.18%
1.71
Other Non Cash Items
7.17
+20.62%
5.95
+10.44%
5.38
-33.86%
8.14
Stock Based Compensation
0.36
-53.70%
0.78
-96.45%
22.11
+411.88%
4.32
Operating Gains Losses
3.27
+129.57%
-11.06
-102.57%
-5.46
-108.95%
60.96
Gain Loss On Investment Securities
3.27
+129.57%
-11.06
-102.57%
-5.46
-108.95%
60.96
Change In Working Capital
-12.73
-560.77%
2.76
+19.56%
2.31
+625.23%
-0.44
Change In Prepaid Assets
-2.66
+16.47%
-3.19
-105.54%
-1.55
-253.87%
1.01
Change In Payables And Accrued Expense
-9.86
-272.53%
5.71
+12.44%
5.08
+948.08%
-0.60
Change In Accrued Expense
-5.11
-246.46%
3.49
+9.54%
3.19
+581.12%
-0.66
Change In Payable
-4.75
-313.45%
2.22
+17.31%
1.90
+2907.94%
0.06
Change In Account Payable
-4.75
-313.45%
2.22
+17.31%
1.90
+2907.94%
0.06
Change In Other Working Capital
0.15
-42.80%
0.27
+153.14%
-0.51
-288.19%
0.27
Change In Other Current Assets
0.02
-94.72%
0.32
0.00
+100.00%
-0.01
Change In Other Current Liabilities
-0.39
-8.76%
-0.35
+50.00%
-0.71
+36.33%
-1.11
Investing Cash Flow
18.21
-21.97%
23.34
+67.20%
13.96
+125.56%
-54.59
Cash Flow From Continuing Investing Activities
18.21
-21.97%
23.34
+67.20%
13.96
+125.56%
-54.59
Net PPE Purchase And Sale
-0.00
+84.62%
-0.01
+79.03%
-0.06
-1.64%
-0.06
Purchase Of PPE
-0.00
+84.62%
-0.01
+79.03%
-0.06
-1.64%
-0.06
Capital Expenditure
-0.00
+84.62%
-0.01
+79.03%
-0.06
-1.64%
-0.06
Net Investment Purchase And Sale
18.21
-22.01%
23.35
+66.55%
14.02
+125.71%
-54.53
Purchase Of Investment
-12.39
+69.91%
-41.18
+9.91%
-45.71
+31.81%
-67.03
Sale Of Investment
30.60
-52.58%
64.53
+8.04%
59.73
+377.82%
12.50
Financing Cash Flow
26.69
+2481.33%
1.03
+156.88%
-1.82
-102.19%
83.13
Cash Flow From Continuing Financing Activities
26.69
+2481.33%
1.03
+156.88%
-1.82
-102.19%
83.13
Net Issuance Payments Of Debt
0.00
0.00
+100.00%
-2.25
+65.45%
-6.52
Issuance Of Debt
—
—
0.00
0.00
Repayment Of Debt
0.00
0.00
+100.00%
-2.25
+65.45%
-6.52
Long Term Debt Issuance
—
—
0.00
0.00
Long Term Debt Payments
0.00
0.00
+100.00%
-2.25
+65.45%
-6.52
Net Long Term Debt Issuance
0.00
0.00
+100.00%
-2.25
+65.45%
-6.52
Net Common Stock Issuance
26.69
+2481.33%
1.03
+138.80%
0.43
-99.52%
89.64
Proceeds From Stock Option Exercised
—
—
—
0.00
Changes In Cash
18.13
+221.18%
-14.96
-136.19%
-6.33
-149.91%
12.69
Effect Of Exchange Rate Changes
-0.07
-22.95%
-0.06
-22.00%
-0.05
-1350.00%
0.00
Beginning Cash Position
6.11
-71.10%
21.13
-23.21%
27.51
+85.68%
14.82
End Cash Position
24.16
+295.72%
6.11
-71.10%
21.13
-23.21%
27.51
Free Cash Flow
-26.77
+31.95%
-39.34
-112.26%
-18.54
-16.55%
-15.90
Interest Paid Supplemental Data
0.00
0.00
-100.00%
0.02
-94.71%
0.42
Income Tax Paid Supplemental Data
0.22
-45.14%
0.40
-51.16%
0.82
+88.74%
0.43
Amortization Of Securities
-0.35
+69.26%
-1.15
-525.68%
-0.18
-128.77%
0.64
Common Stock Issuance
26.69
+2481.33%
1.03
+138.80%
0.43
-99.52%
89.64
Issuance Of Capital Stock
26.69
+2481.33%
1.03
+138.80%
0.43
-99.52%
89.64
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category